// App-Quantinova.ai

2119 : Bimekizumab Treatment Results in Improvements in Fatigue and Pain in Biologic DMARD-Naïve or TNFi-IR Patients with Active Psoriatic Arthritis: Pooled 16-Week Results from Two Phase 3 Randomized, Placebo-Controlled Studies

Researchers

Presenter

  • M. Elaine Husni

Principal Investigators

  • Philip J Mease

  • Joseph Merola

  • Frank Behrens

  • Ennio Giulio Favalli

  • Dennis McGonagle

  • William Tillett

  • Shigeyoshi Tsuji

  • Barbara Ink

  • Deepak Assudani

  • Rajan Bajracharya

  • Jason Coarse

  • Jérémy Lambert

  • Laure Gossec

Medical Centers

  • Cleveland Clinic, Cleveland, OH

  • Swedish Medical Center/Providence St. Joseph Health, Seattle, WA

  • Harvard Medical School, Brigham and Women's Hospital, Boston, MA.

  • Rheumatology University Hospital & Fraunhofer Institute Translational Medicine and Pharmacology, Goethe-University Frankfurt, Frankfurt Am Main, Germany

  • University of Milan, ASST Gaetano Pini-CTO Institute, Milano, Italy

  • Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; National Institute for Health Research, Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

  • Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, United Kingdom

  • Department of Orthopaedics and Rheumatology, Nippon Life Hospital, Osaka, Japan

  • UCB Pharma, Slough, UK Slough United Kingdom

  • UCB Pharma, Raleigh, NC, USA, Raleigh, NC

  • UCB Pharma, Colombes, France, Irigny, France

  • Sorbonne Universites, Paris, France

Locations

  • United States

  • Germany

  • Italy

  • United Kingdom

  • Japan

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

  • Dermatology

Disease

  • Psoriatic arthritis

Biomarkers

  • N/A

Drug/Treatment

  • bimekizumab

  • Adalimumab

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Controlled

Phase

  • III

Study Id's

  • NCT03895203

  • NCT03896581

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved